The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery
Not Applicable
Completed
- Conditions
- Spinal Stenosis
- Interventions
- Drug: control groupDrug: dexmedetomidine group
- Registration Number
- NCT02902380
- Lead Sponsor
- Yonsei University
- Brief Summary
Surgical stress induces stress hormone release and sympathetic hyperactivation. Dexmedetomidine has sympatholytic effect and attenuates stress responses. This study investigate the effect of dexmedetomidine on stress responses and autonomic nervous system balance in patients undergoing major spine surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
- patient between 20 and 70 of age with ASA physical status Ⅰ-Ⅲ
- patient scheduled for major spine surgery
Read More
Exclusion Criteria
- ASA physical status Ⅳ
- congestive heart failure
- severe hepatorenal disease
- insulin dependent DM(diabetes mellitus)
- cancer or metastasis
- pregnancy
- problem with communication
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Group control group 0.9% saline infusion Dexmedetomidine Group dexmedetomidine group dexmedetomidine infusion (0.4 mcg/kg/h) from immediately after anesthetic induction to end of surgery
- Primary Outcome Measures
Name Time Method Stress hormone level 1 hour after the end of surgery The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
🇰🇷Seoul, Korea, Republic of